The Alliance for Multispecialty Research

What The Alliance for Multispecialty Research does

The Alliance for Multispecialty Research, doing business as AMR Clinical, is a U.S. clinical research site network founded in 1994 and headquartered in Knoxville, Tennessee. The company operates a centralized, integrated infrastructure spanning 30+ clinical research sites across the United States, staffed by 100+ investigators across multiple therapeutic specialties. AMR Clinical executes Phase I-IV trials for pharmaceutical sponsors and contract research organizations (CROs), drawing on a proprietary subject database of 1M+ participants to drive enrollment and retention. The organization reports 8,000+ completed studies across all phases and 30+ new drug approvals contributed to in the past five years. A leadership transition was announced in December 2025 via a CEO succession plan.

AMR Clinical's revenue model is professional services: it contracts directly with pharmaceutical sponsors and CROs on a study-by-study basis, with fees typically structured as per-patient or milestone-based compensation for research services rendered across its site network. The go-to-market is sales-led, with a dedicated business development and relationship management motion targeting enterprise buyers seeking consistent enrollment, fast startup, and predictable trial execution. Customer segments are horizontal across the pharmaceutical/biotech and CRO verticals, with use cases spanning vaccines, seasonal vaccine programs, and general pharmaceutical studies. The company also operates participant-facing channels (a "Find a Study" portal, email list, and social media presence) to feed enrollment pipelines.

The core technology is the centralized integrated infrastructure that coordinates trial operations across 30+ physical sites, rather than a software product. AMR Clinical complements this with network-growth programs — a "Become a Site" partner program that onboards external research sites into the network, a "Become an Investigator" program to expand the investigator pool, and a 2025 brand refresh repositioning the company as a fully integrated site partner. A collaboration with Advarra (referenced in Advarra's November 2024 collaboration survey and continued in Advarra's January 2025 study-startup solution announcement) signals ecosystem integration with a leading IRB and clinical technology vendor.

Name

The Alliance for Multispecialty Research

Legal name

Alliance for Multispecialty Research LLC

Website

https://amrllc.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

501–1,000 employees

Short description

AMR Clinical is a U.S. clinical research site network operating 30+ integrated sites across the country, executing Phase I-IV trials for pharmaceutical sponsors and CROs using a 1M+ participant subject database and 100+ investigators.

Ownership category

akta.pro rank

Product category

Clinical Research Site Services

NAICS

Scientific Research and Development Services (5417), All Other Professional, Scientific, and Technical Services (54199)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Clinical research sites
• Clinical trial services
• Multispecialty research
• Pharmaceutical trial execution
• Contract research organization

Headquarters

HQ city

Knoxville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Research Site Services: AMR Clinical generates revenue by providing integrated clinical research site services to pharmaceutical sponsors and CROs. They conduct clinical trials across all phases (Phase I–IV), offering participant enrollment, retention, and data collection services. Revenue is derived from contracted study agreements, typically structured as per-patient or milestone-based fees for research services rendered at their site network locations.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

The Alliance for Multispecialty Research (operating as AMR Clinical) is an integrated clinical research site organization that operates 30+ clinical research sites across the United States, conducting Phase I–IV clinical trials on behalf of pharmaceutical sponsors and contract research organizations (CROs). The company delivers participant enrollment, retention, investigator coverage, and trial execution services through a centralized integrated infrastructure, supported by a 1M+ participant subject database and 100+ investigators across multiple therapeutic specialties.

Product overview

AMR Clinical operates as an integrated clinical research site network offering a unified platform of services. The core offering is the integrated site network with 30+ research sites across the U.S., supported by a database of 1M+ participants and 100+ investigators. Services include participant enrollment (Find a Study portal), trial execution capabilities for sponsors and CROs, investigator recruitment, and site partnership programs. The organization has completed 8,000+ studies across all phases and contributed to 30+ new drug approvals in the past 5 years.

Differentiator

Problem solved

Functional benefit

Products and services

• Integrated Clinical Research Site Services Full-service Phase I–IV clinical trial execution delivered through 30+ research sites under a centralized integrated infrastructure, providing participant enrollment, retention, and data collection for pharmaceutical sponsors and CROs.
• Find a Study (Participant Enrollment) Portal and process enabling prospective participants to search for and enroll in available clinical trials conducted at AMR Clinical's site locations.
• Clinical Research Site Network Network of 30+ strategically located U.S. clinical research sites staffed by 100+ investigators in multiple specialties, providing geographic and therapeutic coverage for sponsor and CRO studies.

Quantifiable outcome

• 30+ new drug approvals in the past 5 years
• +3 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• AdvarracoreStrategic or Co-development Partner · 12 November 2024Advarra published its 2024 Site-Sponsor-CRO Collaboration Survey Results to improve clinical research, with AMR Clinical referenced as a contributing site partner. Advarra also introduced a comprehensive solution to accelerate study startup and improve collaboration on clinical trials in January 2025. The collaboration focuses on improving site-sponsor-CRO collaboration workflows and streamlining study startup processes across the clinical research ecosystem.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Velocity Clinical Research: Velocity Clinical Research operates an integrated U.S. clinical research site network acquired and consolidated from multiple regional SMO operators. Directly comparable to AMR in business model, site-network structure, and target customers (pharma sponsors and CROs).
• CenExel: CenExel is a clinical research site network specializing in early-phase and specialty clinical trials across multiple therapeutic areas. Closely comparable to AMR as a multi-site SMO serving pharma sponsors with integrated infrastructure.
• Flourish Research: Flourish Research operates a U.S. clinical research site network formed by consolidating multiple regional site operators. Directly comparable to AMR's multispecialty site-network model and customer base.
• Javara: Javara is an integrated clinical research site organization partnering with large health systems and physician practices to conduct trials. Comparable to AMR in operating embedded research sites across multiple specialties for pharma and CRO sponsors.
• Accel Research Sites: Accel Research Sites is a clinical research site network running multi-specialty trials across the U.S. Directly comparable to AMR in site-based model, therapeutic breadth, and enterprise sponsor relationships.

Emerging players

• Circuit Clinical: Circuit Clinical operates a community-based clinical trial site network with an emphasis on patient access and decentralized trial models. Comparable to AMR in site-network structure but at smaller scale and with a stronger DCT technology orientation.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO offering site management, patient recruitment, and clinical operations. Comparable to AMR in operating multi-site clinical research for pharma sponsors, though with broader CRO capabilities beyond site services.

Broad incumbents

• IQVIA: IQVIA is the largest global CRO offering site management, clinical monitoring, and real-world evidence services. Comparable as an enterprise competitor to AMR for sponsor outsourced study execution, though IQVIA's portfolio extends well beyond site services.
• Medpace: Medpace is a mid-to-large global CRO with strong site relationships and full-service trial execution. Comparable to AMR as a customer (sponsor partner) and as a competitive alternative for site-driven study execution, though Medpace is a CRO rather than a site network.
• ICON plc: ICON plc is a leading global CRO with significant site and patient recruitment capabilities following its PRA Health Sciences combination. Comparable to AMR as a large enterprise competitor for multi-site Phase II–IV studies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@AMRClinical
• Facebookfacebook.com/amrllc
• LinkedInlinkedin.com/company/alliance-for-multispecialty-research-llc
• Xx.com/amrclintrial

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Alliance for Multispecialty Research